Genetic and environmental underpinnings to age-related ocular diseases.
暂无分享,去创建一个
[1] Sivakumar Gowrisankar,et al. Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration , 2013, Nature Genetics.
[2] Gabriëlle H S Buitendijk,et al. A functional variant in the CFI gene confers a high risk of age-related macular degeneration , 2013, Nature Genetics.
[3] Cynthia A. Toth,et al. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. , 2013, JAMA.
[4] B. Rosner,et al. Dietary omega-3 fatty acids, other fat intake, genetic susceptibility, and progression to incident geographic atrophy. , 2013, Ophthalmology.
[5] Johanna M Seddon,et al. Validation of a prediction algorithm for progression to advanced macular degeneration subtypes. , 2013, JAMA ophthalmology.
[6] Gabriëlle H S Buitendijk,et al. Seven New Loci Associated with Age-Related Macular Degeneration , 2013, Nature Genetics.
[7] J. P. McCoy,et al. Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. , 2012, Cell reports.
[8] Juan Ye,et al. Smoking and risk of age-related cataract: a meta-analysis. , 2012, Investigative ophthalmology & visual science.
[9] M. Daly,et al. Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models. , 2012, Investigative ophthalmology & visual science.
[10] Johanna M Seddon,et al. Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. , 2011, Ophthalmology.
[11] Sivakumar Gowrisankar,et al. A rare penetrant mutation in CFH confers high risk of age-related macular degeneration , 2011, Nature Genetics.
[12] M. Daly,et al. Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe). , 2011, Investigative ophthalmology & visual science.
[13] B. Rosner,et al. Smoking, dietary betaine, methionine, and vitamin D in monozygotic twins with discordant macular degeneration: epigenetic implications. , 2011, Ophthalmology.
[14] Aaron Y. Lee,et al. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration , 2011, Human molecular genetics.
[15] Aaron Y. Lee,et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC) , 2010, Proceedings of the National Academy of Sciences.
[16] B. Rosner,et al. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. , 2009, Investigative ophthalmology & visual science.
[17] R. Klein,et al. Forecasting age-related macular degeneration through 2050. , 2009, JAMA.
[18] Johanna M Seddon,et al. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. , 2009, Investigative ophthalmology & visual science.
[19] E. Souied,et al. [Epidemiology of age related macular degeneration]. , 2009, Journal Francais d'Ophtalmologie.
[20] J. Ott,et al. CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. , 2008, Ophthalmology.
[21] B. Rosner,et al. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. , 2007, JAMA.
[22] Johanna M Seddon,et al. The genetics of age-related macular degeneration: a review of progress to date. , 2006, Survey of ophthalmology.
[23] R. Milton,et al. C-reactive protein and homocysteine are associated with dietary and behavioral risk factors for age-related macular degeneration. , 2006, Nutrition.
[24] A. Ramé. [Age-related macular degeneration]. , 2006, Revue de l'infirmiere.
[25] B. Rosner,et al. CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. , 2006, Human heredity.
[26] Johanna M Seddon,et al. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. , 2005, Archives of ophthalmology.
[27] P. Jong. Prevalence of age-related macular degeneration in the United States. , 2004 .
[28] M. C. Leske,et al. Prevalence of open-angle glaucoma among adults in the United States. , 2004, Archives of ophthalmology.
[29] N. Rifai,et al. Association between C-reactive protein and age-related macular degeneration. , 2004, JAMA.
[30] Ronald Klein,et al. The epidemiology of age-related macular degeneration. , 2004, American journal of ophthalmology.
[31] Harold Snieder,et al. Genetic influence on early age-related maculopathy: a twin study. , 2002, Ophthalmology.
[32] Jennifer I. Lim,et al. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.
[33] C. Mangione,et al. Influence of age-related maculopathy on visual functioning and health-related quality of life. , 1999, American journal of ophthalmology.
[34] J. Seddon,et al. Do age-related macular degeneration and cardiovascular disease share common antecedents? , 1999, Ophthalmic epidemiology.
[35] Lawrence A. Yannuzzi,et al. Dietary Carotenoids, Vitamins A, C, and E, and Advanced Age-Related Macular Degeneration , 1994 .
[36] R Hiller,et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. , 1994, JAMA.